ASX
Clinuvel Pharmaceuticals Limited
CUV:ASX•Healthcare
Sensitive ASX Announcement
Five month study follow up - SCENESSE in vitiligo (CUV102)
Published: 02/09/13, 09:05am (AEST)•3 pages